Abiraterone Acetate 250 mg Tablets Ahabir

Abiraterone Acetate 250 mg tablets, marketed under the brand name Ahabir, is a prescription-only oral oncology medicine containing the active ingredient Abiraterone Acetate. It belongs to the class of hormonal antineoplastic agents and is manufactured for use within regulated oncology treatment frameworks. AmeriDrugs supplies this product strictly for international export to licensed pharmaceutical distributors, hospitals, and cancer care institutions. It is not intended for retail or direct-to-patient sales.

Active Ingredient

• Abiraterone Acetate 250 mg tablets
  Abiraterone Acetate is a steroidal compound that inhibits androgen biosynthesis and is used within approved oncology indications under medical supervision.

Therapeutic Use
From an informational and regulatory standpoint, Abiraterone Acetate is used in approved treatment protocols related to prostate cancer management, as defined by health authorities in the importing country. This information is provided solely for product identification and international trade clarity. AmeriDrugs does not provide medical advice, treatment recommendations, or patient-level guidance.

Dosage Form

• Oral solid dosage form
• Film-coated tablets
• Supplied in bulk packaging suitable for hospital pharmacies and institutional use
• Administration and treatment decisions are determined exclusively by qualified oncology professionals in accordance with local regulations

Quality & Manufacturing Standards
Abiraterone Acetate Tablets IP 250 mg (Ahabir) are manufactured in GMP-compliant facilities operating under validated pharmaceutical quality systems. Production includes raw material verification, in-process quality controls, and finished product testing to ensure identity, strength, purity, and consistency aligned with international export requirements.

Packaging Information

• Pack size: 120 tablets per box
• Pharmaceutical-grade blister or bottle packaging (as applicable)
• Secure secondary packaging designed for international shipping and export logistics
• Labeling compliant with oncology supply and prescription drug regulations

Target Buyers
This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors
• Hospitals and oncology treatment centers
• Government and private cancer care institutions
• Authorized healthcare procurement agencies

It is not intended for retail pharmacies, online consumer sales, or direct patient distribution.

Regulatory & Compliance Note
Abiraterone Acetate Tablets IP 250 mg (Ahabir) is a prescription-only oncology medicine. Importation, distribution, and use must comply with the pharmaceutical laws, drug authority approvals, and oncology regulations of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote this product for self-medication or any non-regulated use.